Business
Curanex Appoints Two Veteran Industry Leaders to Scientific Advisory Board
New Advisors Bring 50+ Years of Leadership Experience With 2 of the Top 10 Global Pharmaceuticals Companies Jericho, New York, March 11, 2026 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals Inc. (Nasdaq: CURX) (“Curanex” or the “Company”), a development-stage pharmaceutical company focused on the discovery and development of botanical drugs for the treatment of inflammatory diseases, today announced the appointment of two highly respected and accomplished life sciences research experts to the Compan
About this update from Merck & Company, Inc.
[{"type":"image","alt":"Curanex Pharmaceuticals Inc","displaySize":"","headline":null,"caption":"Curanex Pharmaceuticals Inc","className":"","disableSlideshowImg":false,"size":{"original":{"width":99,"height":79,"url":"https://media.zenfs.com/en/globenewswire.com/626966b8a79efcc1edbf6826b780ec50"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/bb_jZYMSLXOLF03SK.7iZw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTExMDtoPTg4O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/626966b8a79efcc1edbf6826b780ec50","width":99,"height":79}},"lazy":false},{"type":"text","content":"New Advisors Bring 50+ Years of Leadership Experience With 2 of the Top 10 Global Pharmaceuticals Companies","length":113,"tagName":"p"},{"type":"text","content":"Jericho, New York, March 11, 2026 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals Inc. (Nasdaq: CURX) (“Curanex” or the “Company”), a development-stage pharmaceutical company focused on the discovery and development of botanical drugs for the treatment of inflammatory diseases, today announced the appointment of two highly respected and accomplished life sciences research experts to the Company’s Scientific Advisory Board. Together, Dr. Daniel Pascheles and Dr. Nicholas A. Meanwell have contributed more than 75 years of total pharmaceuticals experience, including a combined 50 years at Merck & Co. and Bristol Meyers Squib.","length":630,"tagName":"p"},{"type":"text","content":"Both Advisors will support all commercial strategy, product portfolio development and go-to-market decisions. Biographical experience for these two new advisors is as follows:","length":175,"tagName":"p"},{"type":"text","content":"Daniel Pascheles, Ph.D.Daniel Pascheles is a pharmaceutical executive and strategic consultant with over 25 years of experience building world-class competitive intelligence organizations within global life sciences companies. He is Former CEO and Partner at Molekule Consulting LLC, a firm he joined in 2017 to advise pharmaceutical and biotechnology clients on competitive strategy and market intelligence.","length":409,"tagName":"p"},{"type":"text","content":"Prior to Molekule Consulting, Dr. Pascheles spent 12 years at Merck & Co./MSD as Vice President and Head of Global Competitive Intelligence. Before that, he held senior leadership roles over 14 years at Aventis and its predecessor companies (Hoechst Marion Roussel, Marion Me...